One Lung Ventilation and Positive End Expiratory Pressure (PEEP)
This study is currently recruiting participants.
Verified July 2012 by Yonsei University
Sponsor:
Yonsei University
Information provided by (Responsible Party):
Yong-Sun Choi, Yonsei University
ClinicalTrials.gov Identifier:
NCT01652612
First received: December 20, 2011
Last updated: July 25, 2012
Last verified: July 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Hypoxia frequently develops during one lung ventilation in the supine position.The objective of this article is to study the impact of preemptive alveolar recruitment and subsequent positive end expiratory pressure on arterial oxygenation and lung mechanics during one lung ventilation in the supine position in patients undergoing thoracic surgery .
| Condition | Intervention |
|---|---|
|
One Lung Ventilation |
Other: PEEP |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Single Group Assignment Masking: Double Blind (Subject, Caregiver) Primary Purpose: Prevention |
| Official Title: | Effects of Positive End-expiratory Pressure on the Oxygenation and Respiratory Mechanics During One-lung Ventilation in the Supine Position |
Further study details as provided by Yonsei University:
Primary Outcome Measures:
- PaO2, number of patients with hypoxia (PaO2< 90mmHg) [ Time Frame: participants will be followed for the duration of anesthesia, an expected average of 3 hours ] [ Designated as safety issue: Yes ]blood samplings after induction of anesthesia, 15 and 30 min after OLV, after the 2nd TLV
Secondary Outcome Measures:
- intrapulmonary shunt [ Time Frame: participants will be followed for the duration of anesthesia, an expected average of 3 hours ] [ Designated as safety issue: No ]blood sampling after induction of anesthesia, 15 and 30 min after OLV, after the 2nd TLV
| Estimated Enrollment: | 90 |
| Study Start Date: | August 2011 |
| Estimated Study Completion Date: | December 2012 |
| Estimated Primary Completion Date: | September 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
No Intervention: Control
zero PEEP
|
|
|
Experimental: OLV strategy: PEEP
1. apply 8 cm H2O positive end expiratoy pressure during one lung ventilation and until the end of surgery
|
Other: PEEP
8 cmH2O PEEP throughout the period of OLV and 2nd TLV
|
Experimental: OLV strategy: PEEP followed by AR
|
Other: PEEP
8 cmH2O PEEP throughout the period of OLV and 2nd TLV
|
Eligibility| Ages Eligible for Study: | 20 Years to 75 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- ASA I-II
- age: 20-75 years
Exclusion Criteria:
- moderate to severe impaired respiratory function,
- heart failure,
- patients' refusal
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01652612
Locations
| Korea, Republic of | |
| Yong Seon Choi | Recruiting |
| Seoul, Korea, Republic of | |
| Contact: Yong seon Choi, M.D. 82-2-2228-5784 yschoi@yuhs.ac | |
| Principal Investigator: Yong Seon Choi, M.D. | |
Sponsors and Collaborators
Yonsei University
More Information
No publications provided
| Responsible Party: | Yong-Sun Choi, assistant professor, Yonsei University |
| ClinicalTrials.gov Identifier: | NCT01652612 History of Changes |
| Other Study ID Numbers: | 4-2011-0301 |
| Study First Received: | December 20, 2011 |
| Last Updated: | July 25, 2012 |
| Health Authority: | South Korea: Korea Food and Drug Administration (KFDA) |
Keywords provided by Yonsei University:
|
positive end expiratory pressure |
ClinicalTrials.gov processed this record on June 18, 2013